Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23003000)

1.

Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults.

Zuckerman IH, Yin X, Rattinger GB, Gottlieb SS, Simoni-Wastila L, Pierce SA, Huang TY, Shenolikar R, Stuart B.

J Am Geriatr Soc. 2012 Oct;60(10):1854-61. doi: 10.1111/j.1532-5415.2012.04165.x. Epub 2012 Sep 24.

2.

The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction.

Di Martino M, Kirchmayer U, Agabiti N, Bauleo L, Fusco D, Perucci CA, Davoli M.

BMJ Open. 2015 Jun 10;5(6):e007866. doi: 10.1136/bmjopen-2015-007866.

3.

[Organisational determinants of adherence to secondary prevention medications after acute myocardial infarction].

Perrone E, Lenzi J, Avaldi VM, Castaldini I, Protonotari A, Rucci P, Piccinni C, Morini M, Fantini MP.

Epidemiol Prev. 2015 Mar-Apr;39(2):106-14. Italian.

PMID:
26036739
4.

Contemporary Trends of Optimal Evidence-Based Medical Therapy at Discharge for Patients Surviving Acute Myocardial Infarction From the Korea Acute Myocardial Infarction Registry.

Lee JH, Bae MH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Cho MC, Kim CJ, Chae SC; Korea Acute Myocardial Infarction Registry Investigators.

Clin Cardiol. 2015 Jun;38(6):350-6. doi: 10.1002/clc.22396. Epub 2015 May 11.

PMID:
25962712
5.

Effect of hospitalization on inappropriate prescribing in elderly Medicare beneficiaries.

Lund BC, Schroeder MC, Middendorff G, Brooks JM.

J Am Geriatr Soc. 2015 Apr;63(4):699-707. doi: 10.1111/jgs.13318. Epub 2015 Apr 8.

PMID:
25855518
6.

Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.

Shore S, Jones PG, Maddox TM, Bradley SM, Stolker JM, Arnold SV, Parashar S, Peterson P, Bhatt DL, Spertus J, Ho PM.

Heart. 2015 May 15;101(10):800-7. doi: 10.1136/heartjnl-2014-306754. Epub 2015 Mar 23.

PMID:
25801001
7.

Increased statin prescribing does not lower pneumonia risk.

Polgreen LA, Cook EA, Brooks JM, Tang Y, Polgreen PM.

Clin Infect Dis. 2015 Jun 15;60(12):1760-6. doi: 10.1093/cid/civ190. Epub 2015 Mar 10.

PMID:
25759433
8.

Use of statins by medicare beneficiaries post myocardial infarction: poor physician quality or patient-centered care?

Schroeder MC, Robinson JG, Chapman CG, Brooks JM.

Inquiry. 2015 Feb 27;52. pii: 0046958015571131. doi: 10.1177/0046958015571131. Print 2015.

PMID:
25724749
9.

Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarction.

Yun H, Safford MM, Brown TM, Farkouh ME, Kent S, Sharma P, Kilgore M, Bittner V, Rosenson RS, Delzell E, Muntner P, Levitan EB.

J Am Heart Assoc. 2015 Feb 9;4(2). pii: e001208. doi: 10.1161/JAHA.114.001208.

10.

Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.

Rosenson RS, Kent ST, Brown TM, Farkouh ME, Levitan EB, Yun H, Sharma P, Safford MM, Kilgore M, Muntner P, Bittner V.

J Am Coll Cardiol. 2015 Jan 27;65(3):270-7. doi: 10.1016/j.jacc.2014.09.088.

PMID:
25614424
11.

Limited impact of drug exposure misclassification from non-benefit thiazolidinedione drug use on mortality and hospitalizations from Saskatchewan, Canada: a cohort study.

Gamble JM, Johnson JA, McAlister FA, Majumdar SR, Simpson SH, Eurich DT.

Clin Ther. 2015 Mar 1;37(3):629-42. doi: 10.1016/j.clinthera.2014.12.014. Epub 2015 Jan 14.

PMID:
25596665
12.

Cost-effectiveness of treatment and secondary prevention of acute myocardial infarction in India: a modeling study.

Megiddo I, Chatterjee S, Nandi A, Laxminarayan R.

Glob Heart. 2014 Dec;9(4):391-398.e3. doi: 10.1016/j.gheart.2014.07.002. Epub 2014 Nov 26.

PMID:
25592792
13.

Self-controlled case-series study to verify the effect of adherence to Beta-blockers in secondary prevention of myocardial infarction.

Di Bartolomeo S, Marino M, Guastaroba P, Valent F, De Palma R.

J Am Heart Assoc. 2015 Jan 7;4(1):e001575. doi: 10.1161/JAHA.114.001575.

14.

Does age modify the relationship between adherence to secondary prevention medications and mortality after acute myocardial infarction? A nested case-control study.

Lenzi J, Rucci P, Castaldini I, Protonotari A, Di Pasquale G, Di Martino M, Perrone E, Forti P, Fantini MP.

Eur J Clin Pharmacol. 2015 Feb;71(2):243-50. doi: 10.1007/s00228-014-1793-8. Epub 2014 Dec 23.

PMID:
25529226
15.

The association between spinal cord injury and acute myocardial infarction in a nationwide population-based cohort study.

Yang TY, Chen HJ, Sung FC, Kao CH.

Spine (Phila Pa 1976). 2015 Feb 1;40(3):147-52. doi: 10.1097/BRS.0000000000000704.

PMID:
25394315
16.

Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.

Griffiths B, Lesosky M, Ntsekhe M.

S Afr Med J. 2014 Jun 17;104(7):483-7. doi: 10.7196/samj.7798.

PMID:
25214049
17.

Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).

Amann U, Kirchberger I, Heier M, Zirngibl A, von Scheidt W, Kuch B, Peters A, Meisinger C.

Am J Cardiol. 2014 Aug 1;114(3):329-35. doi: 10.1016/j.amjcard.2014.04.046. Epub 2014 May 15.

PMID:
24927969
18.

Secondary prevention medication after myocardial infarction: persistence in elderly people over the course of 1 year.

Al-Khadra S, Meisinger C, Amann U, Holle R, Kuch B, Seidl H, Kirchberger I.

Drugs Aging. 2014 Jul;31(7):513-25. doi: 10.1007/s40266-014-0189-x.

PMID:
24919974
19.

Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.

Barry AR, Koshman SL, Norris CM, Ross DB, Pearson GJ.

Pharmacotherapy. 2014 May;34(5):464-72.

PMID:
24877186
20.

Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.

Wang M, Moran AE, Liu J, Coxson PG, Heidenreich PA, Gu D, He J, Goldman L, Zhao D.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):78-85. doi: 10.1161/CIRCOUTCOMES.113.000674. Epub 2014 Jan 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk